BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 33213285)

  • 1. Biomaterials-Driven Sterile Inflammation.
    Chen H; Agrawal DK; Thankam FG
    Tissue Eng Part B Rev; 2022 Feb; 28(1):22-34. PubMed ID: 33213285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inflammasome in host response to biomaterials: Bridging inflammation and tissue regeneration.
    Vasconcelos DP; Águas AP; Barbosa MA; Pelegrín P; Barbosa JN
    Acta Biomater; 2019 Jan; 83():1-12. PubMed ID: 30273748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation-mediated matrix remodeling of extracellular matrix-mimicking biomaterials in tissue engineering and regenerative medicine.
    Xu M; Su T; Jin X; Li Y; Yao Y; Liu K; Chen K; Lu F; He Y
    Acta Biomater; 2022 Oct; 151():106-117. PubMed ID: 35970482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between biomaterials and the immune system: Challenges and opportunities in regenerative medicine.
    Salthouse D; Novakovic K; Hilkens CMU; Ferreira AM
    Acta Biomater; 2023 Jan; 155():1-18. PubMed ID: 36356914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current requirements for polymeric biomaterials in ear, nose and throat medicine].
    Sternberg K
    Laryngorhinootologie; 2009 May; 88 Suppl 1():S1-11. PubMed ID: 19353451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo Evaluation of the Biocompatibility of Biomaterial Device.
    Frazão LP; Vieira de Castro J; Neves NM
    Adv Exp Med Biol; 2020; 1250():109-124. PubMed ID: 32601941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering and Functionalization of Gelatin Biomaterials: From Cell Culture to Medical Applications.
    Bello AB; Kim D; Kim D; Park H; Lee SH
    Tissue Eng Part B Rev; 2020 Apr; 26(2):164-180. PubMed ID: 31910095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomaterials and Regenerative Medicine in Urology.
    Davis NF; Cunnane EM; Quinlan MR; Mulvihill JJ; Lawrentschuk N; Bolton DM; Walsh MT
    Adv Exp Med Biol; 2018; 1107():189-198. PubMed ID: 29340876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updates in immunocompatibility of biomaterials: applications for regenerative medicine.
    Rezaei M; Davani F; Alishahi M; Masjedi F
    Expert Rev Med Devices; 2022 Apr; 19(4):353-367. PubMed ID: 35531761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T lymphocytes as critical mediators in tissue regeneration, fibrosis, and the foreign body response.
    Adusei KM; Ngo TB; Sadtler K
    Acta Biomater; 2021 Oct; 133():17-33. PubMed ID: 33905946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomimetic Tissue Engineering: Tuning the Immune and Inflammatory Response to Implantable Biomaterials.
    Taraballi F; Sushnitha M; Tsao C; Bauza G; Liverani C; Shi A; Tasciotti E
    Adv Healthc Mater; 2018 Sep; 7(17):e1800490. PubMed ID: 29995315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory biocompatibility requirements for biomaterials used in regenerative medicine.
    Williams DF
    J Mater Sci Mater Med; 2015 Feb; 26(2):89. PubMed ID: 25649511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering Immunomodulatory Biomaterials To Tune the Inflammatory Response.
    Vishwakarma A; Bhise NS; Evangelista MB; Rouwkema J; Dokmeci MR; Ghaemmaghami AM; Vrana NE; Khademhosseini A
    Trends Biotechnol; 2016 Jun; 34(6):470-482. PubMed ID: 27138899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the use of genetically modified decellularized biomaterials for tissue engineering and regenerative medicine.
    Zhu D; Jiang Z; Li N; Wang X; Ren L; Ye Y; Pan Y; Yang G
    Adv Drug Deliv Rev; 2022 Sep; 188():114413. PubMed ID: 35777666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key players in the immune response to biomaterial scaffolds for regenerative medicine.
    Chung L; Maestas DR; Housseau F; Elisseeff JH
    Adv Drug Deliv Rev; 2017 May; 114():184-192. PubMed ID: 28712923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is tissue engineering and biomaterials the future for lower urinary tract dysfunction (LUTD)/pelvic organ prolapse (POP)?
    Aboushwareb T; McKenzie P; Wezel F; Southgate J; Badlani G
    Neurourol Urodyn; 2011 Jun; 30(5):775-82. PubMed ID: 21661029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomaterials and Regenerative Medicine in Pain Management.
    Gu X; Carroll Turpin MA; Romero-Ortega MI
    Curr Pain Headache Rep; 2022 Jul; 26(7):533-541. PubMed ID: 35727489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of age-related shifts in cellular function and local microenvironment upon the innate immune response to implants.
    Brown BN; Haschak MJ; Lopresti ST; Stahl EC
    Semin Immunol; 2017 Feb; 29():24-32. PubMed ID: 28539184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing Biomaterials to Modulate Notch Signaling in Tissue Engineering and Regenerative Medicine.
    Zohorsky K; Mequanint K
    Tissue Eng Part B Rev; 2021 Oct; 27(5):383-410. PubMed ID: 33040694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomaterials and 3D printing techniques used in the medical field.
    Mishra A; Srivastava V
    J Med Eng Technol; 2021 May; 45(4):290-302. PubMed ID: 33929285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.